• Win Marks Syra Health's Expansion into its 15th State

CARMEL, Ind., Dec. 21, 2023 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare consulting company with a mission to improve healthcare by providing innovative services and technology solutions, announced today that it has been awarded a contract with the Mississippi Department of Human Services (MDHS) to provide behavioral and mental health services for the Oakley Youth Development Center  and other locations as directed by MDHS.

Under the terms of the contract, Syra Health will implement and oversee a comprehensive evaluation and treatment program for children at the Oakley Youth Development Center. This program will include the participation of licensed psychologists as members of the Individual Education Plan (IEP) and/or Individual Treatment Plan (ITP) committees, who will provide directives for students with identified psychological and behavioral challenges.

The scope of services includes testing special education students, determining their special education eligibility, providing psychological interviewing and screening, and conducting assessments based on the Mississippi Department of Education Policies and the Individuals with Disabilities Act regulations.

"We are honored to have the opportunity to contribute to the well-being of Mississippi's youth through this partnership with the Mississippi Department of Human Services," said Dr. Deepika Vuppalanchi, CEO, Syra Health. "Our team of licensed psychologists is committed to ensuring that children at the Oakley Youth Development Center receive the best possible care and support to thrive academically and emotionally."

Building off of its success in Indiana and New Jersey, this contract is Syra Health's third engagement in three states for providing mental and behavioral health evaluation services.

ABOUT SYRA HEALTH

Syra Health is a healthcare technology company addressing some of healthcare's most significant challenges in areas such as behavioral and mental health, digital health, and population health, by providing innovative services and technology solutions. Syra Health's products and services are centered on prevention, improved access, and affordable care. Syra Health supplies its solutions to payers, providers, life sciences organizations, academic institutions, and government. For more information, please visit www.syrahealth.com.

FORWARD-LOOKING STATEMENTS

Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements." These statements include, but are not limited to, statements relating to the expected use of proceeds, the Company's operations and business strategy and the Company's expected financial results. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to substantial risks, uncertainty and changes in circumstances. Investors should read the risk factors set forth in our registration statement on Form S-1 and other periodic reports filed with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by federal securities laws, the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise.

For more information, please contact:

For Media Inquiries:
Syra Health
Communications and Marketing Director
Christine Drury
463-345-5180 This email address is being protected from spambots. You need JavaScript enabled to view it.

For Investor Inquiries:
Ben Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
This email address is being protected from spambots. You need JavaScript enabled to view it.